Given this defining feature of inflammatory macrophages and experimental evidence suggesting their role in driving NF1-related pathologies such as tumor growth and malignant transformation, targeting glucose internalization or glycolysis specifically in macrophages is an attractive therapeutic approach for persons with NF1. This evidence concerns the gene NF1 and neoplasm.